News Search Results
Jul 23, 2025, 08:30 ET LenioBio secures EUR 3.7M of EU4Health funding to develop ALiCE® for cost-effective and rapid production of protein-based medicines
EU4Health programme by managing calls for proposals and tenders from 2021 to 2027. The programme and its calls represent an ambitious response to the COVID-19 pandemic, but go beyond crisis response to address the resilience of European healthcare systems and contribute to a healthier Europe. EU4Health
More news about: LenioBio
Jul 23, 2025, 03:00 ET LenioBio secures EUR 3.7M of EU4Health funding to develop ALiCE® for cost-effective and rapid production of protein-based medicines
EU4Health programme by managing calls for proposals and tenders from 2021 to 2027. The programme and its calls represent an ambitious response to the COVID-19 pandemic, but go beyond crisis response to address the resilience of European healthcare systems and contribute to a healthier Europe. EU4Health
More news about: LenioBio
Jul 23, 2025, 03:00 ET LenioBio erhält EU4Health-Förderung in Höhe von 3,7 Mio. EUR für die Entwicklung von ALiCE® zur kostengünstigen und schnellen Herstellung von Medikamenten auf Proteinbasis
Aufforderungen zur Einreichung von Vorschlägen und Ausschreibungen verwaltet. Das Programm und seine Aufforderungen stellen eine ehrgeizige Reaktion auf die COVID-19-Pandemie dar, gehen aber über die Krisenreaktion hinaus, um die Widerstandsfähigkeit der europäischen Gesundheitssysteme zu verbessern und zu einem
More news about: LenioBio
Jul 23, 2025, 03:00 ET LenioBio obtient un financement de 3,7 millions d'euros de l'UE4Health pour développer ALiCE® en vue d'une production rapide et rentable de médicaments à base de protéines
gérant les appels à propositions et les appels d'offres de 2021 à 2027. Le programme et ses appels constituent une réponse ambitieuse à la pandémie de COVID-19, mais vont au-delà de la réponse à la crise pour renforcer la résilience des systèmes de santé européens et contribuer à une Europe
More news about: LenioBio
Jul 22, 2025, 15:18 ET Global OTC Drug and Dietary Supplements Market Forecasts Indicate Significant Growth
categories like weight management and sports nutrition are outside the scope of the report. This report is particularly relevant today, now that the COVID-19 pandemic has significantly reshaped consumer attitudes toward health and wellness. There is a growing emphasis on preventive care and self-management
More news about: BCC Research LLC
Jul 22, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Petco Health and Wellness Company, Inc. and Certain Officers - WOOF
in period-over-period net sales from physical locations and digital sites that have been open for the applicable period. In the wake of the COVID-19 pandemic, Petco consistently touted the benefits of pandemic-related tailwinds on its growth and profitability, including comparable sales growth,
More news about: Pomerantz LLP
Jul 22, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against iRobot Corporation and Certain Officers - IRBT
was the first commercially successful RVC, iRobot's business has steadily declined over the past decade, apart from a brief sales bump during the COVID-19 pandemic. Competitors from China undercut the luxury-priced Roomba, while other consumer electronics firms like
More news about: Pomerantz LLP
Jul 22, 2025, 07:00 ET Else Nutrition Applauds Pivotal U.S. Legislative Support for Plant-Based, Non-Soy, Non-Dairy Infant Formula Innovation
statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates,
More news about: Else Nutrition Holdings Inc.
Jul 22, 2025, 05:10 ET Mercantile Bank Corporation Announces Robust Second Quarter 2025 Results and Partnership with Eastern Michigan Financial Corporation
expectations and other facts; changes in the national and local economies; unstable political and economic environments; disease outbreaks, such as the COVID-19 pandemic or similar public health threats, and measures implemented to combat them; and other factors, including those expressed as risk factors,
More news about: Mercantile Bank Corporation
Jul 22, 2025, 05:00 ET Mercantile Bank Corporation Increases Regular Cash Dividend
expectations and other facts; changes in the national and local economies; unstable political and economic environments; disease outbreaks, such as the COVID-19 pandemic or similar public health threats, and measures implemented to combat them; and other factors, including those expressed as risk factors,
More news about: Mercantile Bank Corporation
Jul 21, 2025, 10:15 ET Automated Border Control Market worth $5.03 billion by 2030 - Exclusive Report by MarketsandMarkets™
Bali's Ngurah Rai International Airport. Asia Pacific's strong focus on contactless travel, particularly after COVID-19, and increasing geopolitical security concerns pushed countries to invest in robust and scalable ABC technologies. With a vast population, rising middle-class
More news about: MarketsandMarkets
Jul 21, 2025, 09:00 ET RedHill Receives Positive FDA Feedback on Pathway to Approval of Groundbreaking RHB-204 for Crohn's Disease
Radiation Syndrome (GI-ARS), a Phase 2 study in prostate cancer in combination with Bayer's darolutamide and a Phase 2/3 program for hospitalized COVID-19 patients; (ii) RHB-204, an all-in-one, fixed-dose, orally administered, combination antibiotic therapy with a planned Phase 2 study for Crohn's disease
More news about: RedHill Biopharma Ltd.
Jul 17, 2025, 13:01 ET New PolicyMap and Moody's Analytics Report Reveals Neighborhood Level U.S. Housing Shortage Analysis
"equilibrium" baseline from 2012 to 2018, a period chosen for its relative market stability after the recession and before the disruptions of the COVID-19 pandemic. By analyzing how current vacancy rates differ from those norms, the study estimates where each neighborhood is under- or oversupplied in
More news about: PolicyMap
Jul 17, 2025, 10:43 ET Disrupting Higher Ed: Mateo Valdez Launches Gen Z into the Pro Sports Business World
incapable until I realized the problem wasn't me; it was an outdated system that clung to theory while ignoring real-world application." During the COVID-19 lockdown, he reflected on his education and the arbitrary structures holding it back. "The whole system felt claustrophobic. We're taught to chase
More news about: Disruption Interruption
Jul 17, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Petco Health and Wellness Company, Inc. and Certain Officers - WOOF
in period-over-period net sales from physical locations and digital sites that have been open for the applicable period. In the wake of the COVID-19 pandemic, Petco consistently touted the benefits of pandemic-related tailwinds on its growth and profitability, including comparable sales growth,
More news about: Pomerantz LLP
Jul 17, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against iRobot Corporation and Certain Officers - IRBT
was the first commercially successful RVC, iRobot's business has steadily declined over the past decade, apart from a brief sales bump during the COVID-19 pandemic. Competitors from China undercut the luxury-priced Roomba, while other consumer electronics firms like Samsung
More news about: Pomerantz LLP
Jul 17, 2025, 09:26 ET Arts Service Organizations Receive Support From LA Arts Recovery Fund Via California Community Foundation
of grants made through the Fund and administered by the California Community Foundation. The LA Arts Recovery Fund originated in 2021 during the COVID-19 pandemic to sustain cultural organizations, promote economic recovery, and restore community health and wellbeing.
More news about: California Community Foundation
Jul 17, 2025, 07:30 ET Abbott Reports Second-Quarter 2025 Results
an organic basis, or 7.9 percent when excluding COVID-19 testing-related sales2.Abbott projects full-year 2025 organic sales growth, excluding COVID-19 testing-related sales, to be 7.5% to 8.0%, or 6.0% to 7.0% when including COVID-19 testing-related sales.Abbott projects
More news about: Abbott
Jul 17, 2025, 07:00 ET SK bioscience Submits IND for Phase 1/2 Clinical Trial of Adjuvanted Influenza Vaccine Candidate
SK bioscience previously utilized adjuvants in its COVID-19 vaccine, 'SKYCovione', and now seeks to expand this technology to influenza vaccines as part of its broader platform strategy. NBP607B contains
More news about: SK bioscience
Jul 16, 2025, 13:16 ET AAJ Capital 3 Corp. Announces Definitive Agreement for Qualifying Transaction with XRP Healthcare M&A Holding Inc.
NASA Jet Propulsion Laboratory/Caltech to manufacture and distribute the VITAL ventilator—an emergency device designed by NASA engineers during the COVID-19 crisis—Mr. Swantack spearheaded the formation and spin-off of Spiritus Medical, Inc. He currently serves as Interim CEO and President, overseeing
More news about: XRP Healthcare
Jul 16, 2025, 07:31 ET MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test
commercialized; Lucid's ability to raise additional funding as needed; and other competitive developments. In addition, Lucid continues to monitor the COVID-19 pandemic and the pandemic's impact on Lucid's businesses. These factors are difficult or impossible to predict accurately and many of them are beyond
More news about: Lucid Diagnostics
Jul 16, 2025, 05:15 ET Guidehouse Research Estimates Global Market for Air Quality Technologies in Commercial Buildings Will Grow to Nearly $419 Billion by 2033
Health awareness, which surged after the COVID-19 pandemic, is key market driver BOULDER, Colo., July 16, 2025 /PRNewswire/ -- A new report from
More news about: Guidehouse Research
Jul 15, 2025, 21:00 ET ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO
their ideal characteristics. It has been successfully implemented in areas including human immunodeficiency virus (HIV), hepatitis C, tuberculosis, COVID-19, antibiotics, neglected tropical diseases, and childhood cancers. These initiatives demonstrate that, against the backdrop of a fragmented and small
More news about: Arkbio
Jul 15, 2025, 21:00 ET ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO
their ideal characteristics. It has been successfully implemented in areas including human immunodeficiency virus (HIV), hepatitis C, tuberculosis, COVID-19, antibiotics, neglected tropical diseases, and childhood cancers. These initiatives demonstrate that, against the backdrop of a fragmented and small
More news about: Arkbio
Jul 15, 2025, 16:15 ET Paranovus Entertainment Technology Limited Announces Receipt of a Bid Deficiency Notice from Nasdaq
technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic, the COVID-19 outbreak and its impact on our operations and assumptions underlying or related to any of the foregoing and other risks contained in reports filed
More news about: Paranovus Entertainment Technology Ltd.